The Ministry of Health, Labor and Welfare (MHLW) on December 12 presented a draft outline of the FY2026 drug pricing…
HOME > September 14, 2021
Daily News
September 14, 2021
- MHLW Unapproved Drug Panel Agrees on High Needs for 7 Additional Indications for Fertility Treatments
September 14, 2021
- 16,680 Doses Ruined in Workplace Inoculations; Bayer, Otsuka Too
September 14, 2021
- Kyowa Kirin’s G-Lasta Enters Japan PII Study for Stem Cell Transplant
September 14, 2021
- COVID-19 Jabs Need 3 Month Interval after Antibody Cocktail Use: MHLW
September 14, 2021
- Established Drugs’ Group Boots Up with 6 Firms Plus One Organization
September 14, 2021
- Panel OKs 37 More COVID-19 Jab Health Damage Claims for Compensation
September 14, 2021
- PhRMA Hails Japan's New Pharma Industry Vision
September 14, 2021
- Japan Unveils New Pharma Industry Vision, 1st Update in 8 Years
September 14, 2021
- Obituary: P. Reed Maurer
September 14, 2021
Let’s ditch the stuffy jargon and talk about AI in HR like real humans.One of the biggest myths floating around is that AI is coming to steal our jobs. Newsflash: that’s not happening. Sure, AI can handle the boring stuff…
Novartis’ Pluvicto (lutetium vipivotide tetraxetan (177Lu)) won reimbursement listing in Japan in November as a radioligand therapy (RLT) for PSMA-positive…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…